T2 Biosystems, Inc. 8-K Filing: Key Corporate Updates & Stock Info

$TTOO
Form 8-K
Filed on: 2025-02-14
Source
T2 Biosystems, Inc. 8-K Filing: Key Corporate Updates & Stock Info

Based on the provided excerpt from the financial report, here are the key insights:

  1. Entity Information:
  • Company Name: T2 Biosystems, Inc.
  • CIK: 0001492674
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-36571
  • EIN: 20-4827488
  • Address: 101 Hartwell Avenue, Lexington, MA 02421
  • Phone Number: 781-761-4646
  1. Filing Type and Date:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 13, 2025
  1. Stock Information:
  • Type of Security: Common stock
  • Par Value: $0.001 per share
  1. Context Information:
  • The report covers a specific period that begins and ends on February 13, 2025.
  1. Miscellaneous:
  • The XML structure indicates this is part of an XBRL (eXtensible Business Reporting Language) filing, commonly used for regulatory reporting.

Summary:

This section outlines an 8-K filing by T2 Biosystems, Inc., providing essential corporate information such as the company’s identification, filing details, and stock information. The report is set for a specific date in 2025, suggesting it may contain significant updates or disclosures pertinent to investors or regulators.